Daily Tokens
November 17, 2026

Economics · November 17, 2026 · High impact

Isomorphic Labs raises $5 billion in Series C funding

Isomorphic Labs, the AI drug-discovery company spun out of Google DeepMind in 2021, has raised $5 billion in a Series C round. The company says it will use the money to take drug candidates into clinical trials. Demis Hassabis, who left as Google DeepMind CEO several months ago, leads the company.

A round of this size for an AI drug-discovery company is one of the largest private raises in the sector and marks a shift toward human trials for AI-designed medicines.

Go deeper

More from Economics on Tuesday, November 17